Clinical Trial Update: Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports the termination of a study evaluating very low-dose oral anticoagulation in mechanical heart valve recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Valvular Heart Disease

Snippet

Sponsor: Heart and Diabetes Center North-Rhine Westfalia | Conditions: Mechanical Heart Valve Recipients | Phase 4 | Status: TERMINATED